KELLY ROMANELLY: Open Payments
NPI 1639328537 · PORT ST LUCIE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,177 in 58 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $590 · 2025 $1,177
Food & beverage: $1,177
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $152 |
| Lilly USA, LLC | 7 | $148 |
| Amgen Inc. | 6 | $102 |
| AstraZeneca Pharmaceuticals LP | 5 | $99 |
| Astellas Pharma US Inc | 3 | $97 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $95 |
| Exact Sciences Corporation | 3 | $76 |
| ABBVIE INC. | 3 | $73 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $73 |
| SHIELD THERAPEUTICS INC | 2 | $55 |
Products named: Veozah, XIFAXAN, ZEPBOUND, Ozempic, The Cologuard Plus Collection Kit, QULIPTA, Kerendia, Wegovy.
Industry payments across FL — which companies pay providers there.
